Heather Carter
Family Medicine · Manchester, TNNPI 1457644312
Payments from drug & device makers
Across 130 payments — averaging $15.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$698
- AbbVie$287
- GSK$163
- Pfizer$141
- Novartis$118
- Xeris Pharmaceuticals, Inc.$103
- plus $490 from 12 others
What the payments were for
- Food & beverage$1,93597%
- Education$653%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 49 | $698 |
| AbbVie | 14 | $287 |
| GSK | 12 | $163 |
| Pfizer | 9 | $141 |
| Novartis | 7 | $118 |
| Xeris Pharmaceuticals, Inc. | 6 | $103 |
| Merck | 6 | $76 |
| Boehringer Ingelheim | 5 | $69 |
| AstraZeneca | 4 | $59 |
| Otsuka America Pharmaceutical, Inc. | 4 | $59 |
| Bayer | 3 | $45 |
| Gilead | 2 | $42 |
| Astellas Pharma US Inc | 2 | $32 |
| Esperion Therapeutics, Inc. | 2 | $27 |
| Lilly USA, LLC | 2 | $26 |
| Verona Pharma, Inc. | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Mylan Specialty L.p. | 1 | $15 |
How this compares
$2,000 in reported general payments places this provider in the 65th percentile of 2,087 family medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 71 | $83,040 |
| MounjaroTirzepatide | 41 | $46,575 |
| FarxigaDapagliflozin Propanediol | 20 | $12,404 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $11,274 |
| Omeprazole | 76 | $1,264 |
| Atorvastatin Calcium | 103 | $995 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 26 | $983 |
| Rosuvastatin Calcium | 46 | $566 |
| Azelastine Hcl | 20 | $533 |
| Bupropion XlBupropion Hcl | 21 | $523 |
| Gabapentin | 30 | $513 |
| Telmisartan | 12 | $490 |
| Potassium Chloride | 35 | $487 |
| Lisinopril | 93 | $459 |
| Levothyroxine Sodium | 61 | $428 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $698 | $83,04071 claims |
| Lilly USA, LLCMounjaro | $26 | $46,57541 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $59 | $23,67938 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Manchester
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
- Bridgette FraneyNashville$2M
- Andrew BrockmyreBristol$1.8M
- Marcus LeeTullahoma$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.